After securing FDA approval, Abbott Laboratories and Dexcom will soon launch the first over-the-counter continuous glucose monitors, The Washington Post reported Aug. 5. The devices recently gained ...

Dexcom’s over-the-counter continuing glucose monitor (CGM) has been approved by the Food and Drug Administration (FDA), the company announced Tuesday afternoon. The CGM, dubbed Stelo, consists of a ...

The FDA is allowing Dexcom Stelo to market and sell a continuous glucose monitor to patients without a prescription. The Dexcom Stelo Glucose Biosensor System will be the first over-the-counter CGM on ...

Sept 5 (Reuters) - Abbott (ABT.N), opens new tab has launched its over-the-counter continuous glucose monitoring system in the U.S., the company said on Thursday, making it the second such device on ...

The US Food and Drug Administration (FDA) has cleared Dexcom's Stelo Glucose Biosensor System as the first over-the-counter continuous glucose monitoring (CGM) system. The Stelo system comprises a ...